Active specific immunotherapy with 1E10 anti-idiotype vaccine to treat patients with metastatic colon cancer, phase II.
Phase of Trial: Phase II
Latest Information Update: 08 Mar 2017
At a glance
- Drugs Racotumomab (Primary)
- Indications Adenocarcinoma; Colon cancer
- Focus Therapeutic Use
- 31 Jul 2013 Status changed from active, no longer recruiting to completed as reported by Cuban Clinical Trial Registry.
- 07 Sep 2011 New trial record